Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Assessment of Baclofen for Alcohol Withdrawal in Patients With Chronic Liver Disease and Active Alcohol Consumption

NCT06840652 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT06840652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06840652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Assessment of Baclofen for Alcohol Withdrawal in Patients With Chronic Liver Disease and Active Alcohol Consumption
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 22, 2022
Completion date
July 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abstinence, alcohol withdrawal, alcoholic cirrhosis, medication adherence, medication toxicity